Advertisement

Topics

High-Dose Therapy Before Transplant Effective in Refractory Myeloma

00:51 EDT 22 Jun 2017 | Cancer Networks

Undergoing autologous hematopoietic stem cell transplantation was effective and safe in patients with refractory multiple myeloma, including those patients who are refractory to both proteasome inhibitors and immunomodulatory agents.

Original Article: High-Dose Therapy Before Transplant Effective in Refractory Myeloma

NEXT ARTICLE

More From BioPortfolio on "High-Dose Therapy Before Transplant Effective in Refractory Myeloma"

Quick Search
Advertisement
 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...